BMO Capital lowers Sprouts Farmers Market stock price target on expected comp deceleration

BMO Capital has lowered its price target on Sprouts Farmers Market (SFM) to $170 from $180, while maintaining a Market Perform rating, despite the specialty grocer's strong recent performance including 10% comparable sales growth and a Q2 2025 earnings and revenue beat. The adjustment reflects BMO's anticipation of modest comparable sales deceleration and potential second-half margin headwinds, such as tough shrink comparisons and increased self-distribution investments, which could lead to multiple compression and keep the stock range-bound.

Analysis

BMO Capital has adjusted its outlook on Sprouts Farmers Market (SFM), lowering its price target to $170.00 from $180.00 while maintaining a Market Perform rating. This decision comes despite a period of exceptional performance for the specialty grocer, which reported strong comparable sales growth of 10% and a greater-than-expected gross margin of 38.72% in its recent quarter. The company also surpassed analyst expectations with Q2 2025 revenue of $2.2 billion and a 9.76% earnings per share surprise at $1.35. This robust operational execution has contributed to a 15.51% revenue growth over the last twelve months and a 58.23% stock return over the past year. However, BMO's caution stems from forward-looking factors. The firm noted that Sprouts' guidance for a two-year comparable sales stack of 15% implies a material deceleration from the current growth rate. Furthermore, BMO anticipates margin headwinds in the second half of the year due to challenging shrink comparisons, reduced supply chain expense leverage, and investments in self-distribution. These potential pressures underpin the view that the stock could face modest multiple compression and become range-bound, justifying the neutral stance despite the recent financial strength.

Key Decisions for Investors

• Investors should weigh Sprouts' proven operational strength, highlighted by its 10% comparable sales growth and Q2 2025 earnings beat, against the stock's significant 58.23% run-up over the past year.
• It is prudent to monitor for the anticipated deceleration in comparable sales growth, as company guidance suggests a slowdown from the current strong pace is likely in upcoming quarters.
• Closely evaluate the risk of second-half margin compression from identified headwinds like shrink and supply chain investments, as these factors could cap further upside and justify BMO's thesis of a range-bound stock.